The FDA has approved Incyte's Opzelura cream for atopic dermatitis, commonly called eczema, becoming the first and only topical JAK inhibitor registered in the US. Opzelura (ruxolitinib) – which has ...
Galapagos has signed a deal to jettison its troubled JAK inhibitor drug Jyseleca, agreeing to sell the rights to rheumatoid arthritis and ulcerative colitis therapy to Italy’s Alfasigma SpA in a deal ...
Kutilové, kteří si sami doma něco stavějí, obvykle využívají jekly, trubky, pásovou ocel či kulatiny. A pak jsou tu například i kutilové, kteří si svépomocí staví vlastní bydlení. Při tom využívají pr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results